282 related articles for article (PubMed ID: 16959990)
1. IRBs: going too far or not far enough?
Felten DL
Science; 2006 Sep; 313(5792):1388-9; author reply 1388-9. PubMed ID: 16959990
[No Abstract] [Full Text] [Related]
2. Are human research subjects safe enough?
Thompson RE
Physician Exec; 2003; 29(4):52-4. PubMed ID: 14650072
[No Abstract] [Full Text] [Related]
3. A taxonomy of value in clinical research.
Casarett DJ; Karlawish JH; Moreno JD
IRB; 2002; 24(6):1-6. PubMed ID: 12683394
[No Abstract] [Full Text] [Related]
4. Ethics. Human health research ethics.
Silbergeld E; Lerman S; Hushka L
Science; 2004 Aug; 305(5686):949. PubMed ID: 15310879
[No Abstract] [Full Text] [Related]
5. Bioethical malpractice: risk and responsibilities in human research.
Noah BA
J Health Care Law Policy; 2004; 7(2):175-241. PubMed ID: 15573441
[No Abstract] [Full Text] [Related]
6. Recurrent issues in the review of medical research on human subjects.
Moore DL
Albany Law J Sci Technol; 1991; 1():1-33. PubMed ID: 16296123
[No Abstract] [Full Text] [Related]
7. IRBs: going too far or not far enough?
Vogt TM
Science; 2006 Sep; 313(5792):1388-9; author reply 1388-9. PubMed ID: 16964629
[No Abstract] [Full Text] [Related]
8. IRBs and the long-term social implications of research.
de Melo-Martin I
Am J Bioeth; 2011 May; 11(5):22-3. PubMed ID: 21534145
[No Abstract] [Full Text] [Related]
9. Research involving children: regulations, review boards and reform.
Gandhi R
J Health Care Law Policy; 2005; 8(2):264-330. PubMed ID: 16471026
[No Abstract] [Full Text] [Related]
10. The ethics of clinical trials: to inform or not inform? That is the question.
Spence EH
Prof Ethics; 1998; 6(3-4):173-84. PubMed ID: 11838496
[No Abstract] [Full Text] [Related]
11. Introduction to special issue of Accountability in Research on the review and approval of biomedical research proposals: a call for a centralized national human research protections system.
Mann H; Shamoo AE
Account Res; 2006; 13(1):1-9. PubMed ID: 16770856
[No Abstract] [Full Text] [Related]
12. Module five: implementation of ethics review.
Dhai A
Dev World Bioeth; 2005 Mar; 5(1):73-91. PubMed ID: 15748179
[TBL] [Abstract][Full Text] [Related]
13. IRBs, data sharing, and privacy of human subjects.
Maloney DM
Hum Res Rep; 2002 Apr; 17(4):3. PubMed ID: 12374179
[No Abstract] [Full Text] [Related]
14. Extend the reach of institutional review boards first, then strengthen their depth.
Spike J
Am J Bioeth; 2008 Nov; 8(11):11-2. PubMed ID: 19061097
[No Abstract] [Full Text] [Related]
15. Financial conflicts of interest and protection of human research subjects.
Maloney DM
Hum Res Rep; 2004 Jun; 19(6):1-2. PubMed ID: 15462034
[No Abstract] [Full Text] [Related]
16. Assessing benefits in clinical research: why diversity in benefit assessment can be risky.
Churchill LR; Nelson DK; Henderson GE; King NM; Davis AM; Leahey E; Wilfond BS
IRB; 2003; 25(3):1-8. PubMed ID: 14569987
[No Abstract] [Full Text] [Related]
17. IRBs, human subjects, and reporting adverse events.
Maloney DM
Hum Res Rep; 2005 Nov; 20(11):3. PubMed ID: 16358480
[No Abstract] [Full Text] [Related]
18. Thinking further about value: commentary on "A taxonomy of value in clinical research".
Grady C
IRB; 2002; 24(6):7-8. PubMed ID: 12683395
[No Abstract] [Full Text] [Related]
19. Clinical trials. Proposed rules aim to curb financial conflicts of interest.
Kaiser J
Science; 2002 Jan; 295(5553):246-7. PubMed ID: 11786611
[No Abstract] [Full Text] [Related]
20. Creative solutions: research subject advocates: increase in reports of human subject protection deficiencies bring scrutiny as well as more efforts at education and support.
O'Lonergan T
Prot Hum Subj; 2003; (8):10-1. PubMed ID: 16178110
[No Abstract] [Full Text] [Related]
[Next] [New Search]
